Motilal Oswal’s private equity arm has agreed to invest up to Rs 460 crore ($53 million) for a majority stake in Megafine Pharma, an export-focused Active Pharmaceutical Ingredients (API) company, according to an announcement.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
